Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Registry Hub

Therapeutic Classification

nucleoside reverse transcriptase inhibitor Registry

Clinical reference for nucleoside reverse transcriptase inhibitor medications. Access safety monographs, dosing adjustments, and drug-drug interactions for all registered brand names and generics in this class.

Registered Medications (nucleoside reverse transcriptase inhibitor)

This therapeutic registry is dynamically synthesized from professional clinical sources. Listing of a medication does not imply equivalence; refer to individual monographs for head-to-head pharmacological data.

MedicationTherapeutic ClassMaternal Safety

ABACAVIR SULFATE

Abacavir use in pregnancy has limited human data; animal studies showed no teratogenicity. It is recommended when benefit outweighs risk, with preference for alternatives in women of childbearing potential if HLA-B*5701 positive.

Nucleoside reverse transcriptase inhibitor

caution

DALVANCE

Comprehensive clinical and safety monograph for DALVANCE (DALVANCE).

Non-Nucleoside Reverse Transcriptase Inhibitor

caution

ENTECAVIR

Drugs that reduce renal function may increase levels Severe acute exacerbations of hepatitis B have been reported upon discontinuation.

Nucleoside Reverse Transcriptase Inhibitor

safe

SUSTIVA

Comprehensive clinical and safety monograph for SUSTIVA (SUSTIVA).

Non-Nucleoside Reverse Transcriptase Inhibitor

caution

TRIZIVIR

Comprehensive clinical and safety monograph for TRIZIVIR (TRIZIVIR).

Nucleoside Reverse Transcriptase Inhibitor (NRTI) Combination

caution

VEMLIDY

Comprehensive clinical and safety monograph for VEMLIDY (VEMLIDY).

Nucleoside Reverse Transcriptase Inhibitor (NRTI) for HBV

caution

VIDEX

Comprehensive clinical and safety monograph for VIDEX (VIDEX).

Nucleoside Reverse Transcriptase Inhibitor

caution

VIDEX EC

Comprehensive clinical and safety monograph for VIDEX EC (VIDEX EC).

Nucleoside Reverse Transcriptase Inhibitor

caution